Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0002124509-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 28, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
9,950
Total Value
$848,213.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Global Commercialization Officer | Common Stock | โ | Sep 24, 2026 | Sale | 587 | $200.00 | $117,400.00 | 39,765 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 25, 2026 | Exercise/Conversion | 3,121 | $33.62 | $104,928.02 | 42,886 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Common Stock | โ | Sep 25, 2026 | Sale | 3,121 | $200.54 | $625,885.34 | 39,765 | Direct | โ | View Details | |
Chief Global Commercialization Officer | Stock Option (Right to Buy) | Derivative | Sep 25, 2026 | Exercise/Conversion | 3,121 | $0.00 | $0.00 | 93,625 | Direct | โ | View Details |